Sec Form 13D Filing - BAIN CAPITAL CREDIT MEMBER LLC filing for BAIN CAP SPECIALTY FIN INC (BCSF) - 2020-06-08

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934
(Amendment No. 8)*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

EXPLANATORY NOTE

This Amendment No. 8 to the statement on Schedule 13D (this “Amendment No. 7”) amends the Schedule 13D originally filed by the Reporting Persons with the United States Securities and Exchange Commission (the “SEC”) on October 18, 2016, as further amended by the Amendment No. 1 to Schedule 13D filed on January 24, 2017, the Amendment No. 2 to Schedule 13D filed on February 17, 2017, the Amendment No. 3 to Schedule 13D filed on June 27, 2017, the Amendment No. 4 to Schedule 13D filed on January 18, 2018, the Amendment No. 5 to Schedule 13D filed on November 19, 2018, the Amendment No. 6 to Schedule 13D filed on May 15, 2019, and the Amendment No. 7 to Schedule 13D filed on July 24, 2019 (as so amended, the “Schedule 13D”), relating to the Common Stock, $0.001 par value per share (“Common Stock”), of Bain Capital Specialty Finance, Inc., a Delaware corporation (the “Issuer”). Unless otherwise indicated, all capitalized terms used herein in this Amendment No. 8 shall have the meanings ascribed to them in the Schedule 13D, and unless amended or supplemented hereby, all information previously filed remains in effect.

ITEM 3.                                                                                                SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

Item 3 of the Schedule 13D is hereby amended and supplemented by adding the following:

As described in Item 5 below, on June 5, 2020, F Holdings and MRF Holdings exercised rights to acquire shares of Common Stock issued in connection with the Issuer’s rights offering described in the final prospectus filed by the Issuer pursuant to Rule 497 under the Securities Act with the SEC on May 8, 2020 (the “Rights Offering”). Such shares of Common Stock will be acquired by or on behalf of F Holdings and MRF Holdings using investment capital.  Pursuant to the exercise of their primary subscription rights, F Holdings will pay aggregate consideration of $18,633,778.52 and MRF Holdings will pay aggregate consideration of $3,585,135.12.

ITEM 5.                                                                                                INTEREST IN SECURITIES OF THE ISSUER

Item 5 of the Schedule 13D is hereby amended and supplemented by adding the following:

(a)         and (b) The information set forth in Rows 7 through 13 of the cover pages to this Amendment No. 8 to the Schedule 13D is hereby incorporated herein by reference for each Reporting Person.

(c)          In connection with the Rights Offering, on June 5, 2020, F Holdings and MRF Holdings each exercised in full its primary subscription rights (every 4 subscription rights entitling it to purchase 1 share of Common Stock), which were issued to holders of Common Stock on the May 13, 2020 record date. F Holdings received and exercised 7,293,065 primary subscription rights and will acquire 1,823,266 shares of Common Stock pursuant thereto. MRF Holdings received and exercised 1,403,187 primary subscription rights and will acquire 350,796 shares of Common Stock pursuant thereto. In connection with the Rights Offering, each of F Holdings and MRF Holdings has also exercised its over-subscription privilege and may acquire additional shares of Common Stock pursuant thereto. The number of shares to be acquired pursuant to the over-subscription privilege depends on the number of shares of Common Stock subscribed for by other stockholders and has not yet been communicated to the Reporting Persons.   The subscription price for the Rights Offering is $10.22 per share.

Except for the transactions described above, there have been no other transactions in the securities of the Issuer effected by the Reporting Persons during the past 60 days.

ITEM 7.                                                                                                MATERIAL TO BE FILED AS EXHIBITS

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.